{
    "nctId": "NCT02121145",
    "officialTitle": "Cross-reactive Immunity Elicited by Oral and Parenteral Typhoid Vaccines Against Non-typhoid Salmonellae",
    "inclusionCriteria": "1. Male or female subjects aged \u226518 to \u226465 years\n2. General good health as established by medical history and physical examination\n3. Written informed consent\n4. Females of childbearing potential must agree to use an efficacious hormonal or barrier method of birth control during the study. Abstinence is acceptable.\n5. Available for all visits scheduled in this study.\n* Must have minimum age of 18 Years\n* Must have maximum age of 64 Years",
    "exclusionCriteria": "1. Primary groups: Vaccination against typhoid fever within 5 years before dosing.\n2. History of clinical typhoid fever, clinical paratyphoid A or B fever.\n3. Immunization with any other vaccine (oral or parenteral) within 4 weeks prior to study start or planned vaccination during the study\n4. Current intake of antibiotics or end of antibiotic therapy \\<8 days before first IMP administration\n5. Chronic (longer than 14 days) administration of immunosuppressants or other immune-modifying drugs within 6 months before the first dose of investigational vaccine; oral corticosteroids in dosages of \u22650.5 mg/kg/d prednisolone or equivalent are excluded; inhaled or topical steroids are allowed\n6. Acute or chronic clinically significant gastrointestinal disease"
}